September 16, 2014
Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved testosterone recovery than those who underwent radiotherapy plus 36 months of androgen deprivation, according to results of a randomized phase 3 study presented at the ASTRO Annual Meeting.
“Those who recover normal testosterone value have better quality of life,” Abdenour Nabid, MD, radiation oncologist at Centre Hospitalier Universitaire de Sherbrooke and associate professor at the University of Sherbrooke in Quebec, Canada, said during a press conference. “A higher proportion of patients [assigned 18 months of androgen deprivation therapy] recovered normal testosterone value, and they did so in a much shorter time. This was done without any apparent detriment to long-term outcomes.”